Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders

Eugene R. Schiff, Jules L. Dienstag, Selim Karayalcin, Ian S. Grimm, Robert P. Perrillo, Petr Husa, R. A. De Man, Zachary Goodman, Lynn D. Condreay, Lynn M. Crowther, Mary A. Woessner, Penny J. McPhillips, Nathaniel A. Brown

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders'. Together they form a unique fingerprint.

Medicine & Life Sciences